Impar Servicos Hospitalares SA Hospital Nove de Julho

São Paulo 01409-002

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer, Carcinoma, Non-small-Cell Lung

Studies at this site

• A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer — Recruiting now
• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling